by Kayt Sukel
Cells transplanted into brains of people with late-stage Parkinson’s remained functional for more than a decade after implant.by Jim Schnabel
report promising results from a small clinical trial of an SSRI drug to lower
amyloid beta levels, but years of further tests lie ahead.by Moheb Costandi
How much should we enhance our brains, how far should we go to treat risky pre-term pregnancies, and when can we morally do research on people having surgery for something else were among the topics at the William Safire Seminar on Neuroethics.by Kayt Sukel
Reducing fat levels in obese mice through exercise or surgery appears to result in better cognitive performance.by Brenda Patoine
By The New York Academy of Sciences
Dana grantee Elizabeth Spelke discusses the future direction of arts and cognition research, and puts into perspective the media attention given to her recently published study on the effects of music classes on math abilities in children. One of our series of Scientist Q & As
The search for a treatment for Alzheimer's Disease becomes increasingly urgent as global populations grow and age. In this podcast, leading experts from different sections of the research and development pipeline discuss cutting-edge approaches to developing treatments.By Christie D. Fowler, Ph.D., Brian Lee, Ph.D., and Paul J. Kenny, Ph.D.
Techniques like optogenetics and DREADDs, which control neuronal activity, are revolutionizing our understanding of the central nervous system. Understanding each technique's advantages and disadvantages, and tailoring their use to best address the specific research question under consideration, is key. One of our series of Reports on Progress.